Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,354 | -10,993 | -8,092 | -5,616 | -3,020 |
| Depreciation Amortization | 54 | 171 | 124 | 71 | 34 |
| Other Working Capital | -3 | 210 | 362 | 224 | 622 |
| Other Operating Activity | 204 | 1,245 | 358 | 314 | 148 |
| Operating Cash Flow | $-2,099 | $-9,367 | $-7,248 | $-5,007 | $-2,216 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8 | -432 | -386 | -174 | -35 |
| Purchase Of Investment | -2,262 | -7,539 | -6,960 | -3,412 | -2,431 |
| Sale Of Investment | 2,865 | 11,358 | 9,482 | 6,098 | 4,577 |
| Other Investing Activity | -1 | -255 | -254 | -250 | -250 |
| Investing Cash Flow | $593 | $3,131 | $1,883 | $2,262 | $1,862 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 4,000 | 4,000 | N/A | N/A |
| Common Stock Issued | 10,000 | 3,439 | 3,439 | 3,439 | 3,439 |
| Other Financing Activity | -70 | -696 | -694 | -540 | -511 |
| Financing Cash Flow | $9,930 | $6,743 | $6,745 | $2,899 | $2,928 |
| Beginning Cash Position | 794 | 287 | 287 | 287 | 287 |
| End Cash Position | 9,219 | 794 | 1,667 | 441 | 2,862 |
| Net Cash Flow | $8,425 | $507 | $1,380 | $154 | $2,575 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,099 | -9,367 | -7,248 | -5,007 | -2,216 |
| Capital Expenditure | -8 | -432 | -386 | -174 | -35 |
| Free Cash Flow | -2,107 | -9,800 | -7,635 | -5,180 | -2,250 |